📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor. (2018)

First Author: Wang Z

Attributed to: Tracking hydrogel therapeutics using quantitative whole-body imaging funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41419-018-0573-2

PubMed Identifier: 29795262

Publication URI: http://europepmc.org/abstract/MED/29795262

Type: Journal Article/Review

Volume: 9

Parent Publication: Cell death & disease

Issue: 6